Prior findings from studies of HbA1c and other markers of subclinical atherosclerosis have reported contrasting findings.
Prior findings about modifiers are inconsistent, and most of these studies were conducted in developed countries.
Consistent with prior findings, inventing does not adversely affect research output.
Consistent with prior findings, the calculation yielded a significant result (z value = 2.24, p < .05).05
This pattern is consistent with prior findings (e.g., [20, 21, 38, 66, 67]).
Our results confirm prior findings with respect to the substantial variation in disclosure compliance.
These sex-discrepancies are in accordance with many prior findings [5, 62].
Nevertheless, for atomicity violation and order violation, our results are similar to prior findings [1].
These results replicate prior findings (Cunningham & Wolfe, 2014; Wolfe, 2012a, 2012b).
These data support and extend prior findings by our group and others.
Surprisingly, our results do not match prior findings in the extant literature.
